1927 related articles for article (PubMed ID: 18539529)
21. Sarcopenic-obesity and cardiovascular disease risk in the elderly.
Stephen WC; Janssen I
J Nutr Health Aging; 2009 May; 13(5):460-6. PubMed ID: 19390754
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity.
Öztürk ZA; Türkbeyler İH; Abiyev A; Kul S; Edizer B; Yakaryılmaz FD; Soylu G
Intern Med J; 2018 Aug; 48(8):973-981. PubMed ID: 29665258
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of sarcopenia in patients with respiratory failure classified as normally nourished using computed tomography and subjective global assessment.
Sheean PM; Peterson SJ; Gomez Perez S; Troy KL; Patel A; Sclamberg JS; Ajanaku FC; Braunschweig CA
JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):873-9. PubMed ID: 23980135
[TBL] [Abstract][Full Text] [Related]
24. Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection.
Lodewick TM; Roeth AA; Olde Damink SW; Alizai PH; van Dam RM; Gassler N; Schneider M; Dello SA; Schmeding M; Dejong CH; Neumann UP
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):155-63. PubMed ID: 26136191
[TBL] [Abstract][Full Text] [Related]
25. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of sarcopenic obesity and association with metabolic syndrome in an adult Iranian cohort: The Fasa PERSIAN cohort study.
Siervo M; Rubele S; Shannon OM; Prado CM; Donini LM; Zamboni M; Homayounfar R; Farjam M; Faghih S; Mazidi M
Clin Obes; 2021 Aug; 11(4):e12459. PubMed ID: 33946126
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Sarcopenia and Sarcopenic Obesity in an Academic Total Joint Arthroplasty Practice.
DeMik DE; Marinier MC; Glass NA; Elkins JM
Arthroplast Today; 2022 Aug; 16():124-129. PubMed ID: 35677943
[TBL] [Abstract][Full Text] [Related]
28. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
29. Chronic kidney disease and high eGFR according to body composition phenotype in adults with normal BMI.
Hyun YY; Lee KB; Rhee EJ; Park CY; Chang Y; Ryu S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1088-1095. PubMed ID: 27776918
[TBL] [Abstract][Full Text] [Related]
30. CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.
Fehrenbach U; Wuensch T; Gabriel P; Segger L; Yamaguchi T; Auer TA; Beetz NL; Denecke C; Kröll D; Raakow J; Knitter S; Chopra S; Thuss-Patience P; Pratschke J; Hamm B; Biebl M; Geisel D
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208070
[TBL] [Abstract][Full Text] [Related]
31. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score.
Kim JH; Cho JJ; Park YS
J Korean Med Sci; 2015 Mar; 30(3):264-71. PubMed ID: 25729248
[TBL] [Abstract][Full Text] [Related]
32. Associations of sarcopenic obesity versus sarcopenia alone with functionality.
Bahat G; Kilic C; Ozkok S; Ozturk S; Karan MA
Clin Nutr; 2021 May; 40(5):2851-2859. PubMed ID: 33940398
[TBL] [Abstract][Full Text] [Related]
33. The impact of sarcopenic obesity on treatment outcomes in gastrointestinal cancer: A systematic review.
Dikova TS; Zatsepina AY; Fedorinov DS; Lyadov VK
Clin Nutr ESPEN; 2022 Feb; 47():135-146. PubMed ID: 35063193
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of sarcopenia, sarcopenic obesity, and phase angle in geriatric gastrointestinal cancer patients: before and after chemotherapy.
Hopancı Bıçaklı D; Çehreli R; Özveren A; Meseri R; Uslu R; Karabulut B; Akçiçek F
Turk J Med Sci; 2019 Apr; 49(2):583-588. PubMed ID: 30997793
[TBL] [Abstract][Full Text] [Related]
35. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
McBreairty LE; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
BMC Endocr Disord; 2019 Jul; 19(1):70. PubMed ID: 31262307
[TBL] [Abstract][Full Text] [Related]
36. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
37. Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study.
Lee S; Kim TN; Kim SH
Arthritis Rheum; 2012 Dec; 64(12):3947-54. PubMed ID: 23192792
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of body composition phenotypes in patients with COPD: a retrospective analysis.
Machado FVC; Schneider LP; Fonseca J; Belo LF; Bonomo C; Morita AA; Furlanetto KC; Felcar JM; Rodrigues A; Franssen FME; Spruit MA; Pitta F; Hernandes NA
Eur J Clin Nutr; 2019 Nov; 73(11):1512-1519. PubMed ID: 30643222
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.
Nattenmüller J; Wochner R; Muley T; Steins M; Hummler S; Teucher B; Wiskemann J; Kauczor HU; Wielpütz MO; Heussel CP
PLoS One; 2017; 12(1):e0169136. PubMed ID: 28107410
[TBL] [Abstract][Full Text] [Related]
40. Obesity Measures and Definitions of Sarcopenic Obesity in Singaporean Adults - the Yishun Study.
Pang BWJ; Wee SL; Lau LK; Jabbar KA; Seah WT; Ng DHM; Tan QLL; Chen KK; Jagadish MU; Ng TP
J Frailty Aging; 2021; 10(3):202-210. PubMed ID: 34105702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
